✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchMental HealthNeurologySafety Why This Matters Clinicians need to understand the current evidence base for cannabis...
Zurich’s Weed Trial Is Working So Well Switzerland Just Extended It Again | High Times
✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic PolicyAccess ModelsInternational ResearchClinical ImplementationRegulatory Framework Why This MattersReal-world policy implementations provide crucial data...
Cannabinoid-based interventions for behavioral outcomes in children and adolescents with autism spectrum disorder: A systematic review of safety and effectiveness.
Autism spectrum disorder (ASD) lacks effective options for core symptoms. Cannabinoids, especially cannabidiol (CBD) and combined CBD:ฮ9-tetrahydrocannabinol…
Joseph Schradie, 1933- 2026: UT professor was early advocate for medical marijuana
✦ New CED Clinical Relevance #76Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Medical HistoryCannabis AdvocacyAcademic MedicinePolicy ReformResearch Foundation Why This MattersEarly academic advocates like Professor Schradie...
McGrath named inaugural research fellow of Institute of Cannabis Research
✦ New CED Clinical Relevance #45 Clinical Context Background information relevant to the evolving cannabis medicine landscape. ResearchPolicyCBDTHC Clinical Summary # Clinical Summary The University of Colorado's Institute of Cannabis Research has...
Recent research has revealed that cannabis leaves contain rare compounds that scientists …
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic ResearchPhytochemicalsEvidence QualityPlant ChemistryClinical Validation Why This MattersWithout access to the specific research findings, this...
Faster cannabinoid bioavailability, a study
This cannabinoid bioavailability review looks at a 2025 crossover study testing a nanoemulsified THC/CBD powder against standard oil drops in healthy volunteers. The study found faster absorption and higher cannabinoid exposure with the powder formulation. But cannabinoid bioavailability is not the same as proven clinical benefit, and that distinction matters for patients, providers, and policymakers.
7 Insights from a New Study on Cannabis Oil for Chronic Pain
Cannabis Oil for Chronic Pain Chronic painโa relentless companion for millions worldwideโhas a knack for dodging the best efforts of conventional treatment regimes, leaving countless individuals in a perpetual state of discomfort...
Endorsements announced for the Doctor-Approved Cannabis Handbook
I'm absolutely thrilled to share with you the upcoming launch of my very own "Doctor-Approved Cannabis Handbook". This has been a labour of love, the fruit of years of intense research, and...
The Dose Dependence of Delta-9 THC in Place Conditioning Paradigms
Cannabis aversion in mice increases at higher doses of THC How much is too much when it comes to marijuana use? While marijuana in small doses can be rewarding, high doses could...